ArticleNaunyn-Schmiedeberg's archives of pharmacology2026

Targeting AMPK with ivabradine attenuates cyclophosphamide-induced hepatotoxicity: Crosstalk with MAPK, JAK1/STAT3, and PI3K/Akt pathways.

Ahmed M El-Dessouki et al.PubMed ↗Publisher ↗

No numbers read from the abstract.